| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 8, 337-342, Copyright © 1994 by The Federation of American Societies for Experimental Biology
REVIEWS |
BD Stollar
Department of Biochemistry, Tufts University School of Medicine, Boston, Massachusetts 02111.
There are two major reasons for interest in antibodies to DNA: autoantibodies to DNA are characteristic of the autoimmune disease systemic lupus erythematosus and contribute to its pathology; and both autoantibodies and experimentally induced antibodies to nucleic acids serve as useful biochemical reagents. Physical biochemistry and molecular biology are applied increasingly to questions of the structure and origin of antibodies to DNA and how antibodies recognize specific structures in DNA. Cloning of cDNA for Ig V regions of anti- DNA antibodies reveals that some cells making IgG disease-related autoantibodies are derived from precursor cells that produce natural autoantibodies unrelated to disease. In addition, some immunization- induced antibodies to DNA use gene segments similar to those found in autoantibodies. Cloning and expression of recombinant V regions allow detailed analysis of antibody structures required for DNA binding. Domain swapping and mutagenesis with vectors for bacterial expression of single chain Fv molecules revealed the importance of CDR3 sites of both H and L chain V regions for specific antigen binding by antibody to Z-DNA. In certain autoantibodies, the H chain plays a dominant role in determining DNA binding. Molecular analysis opens doors to studies of normal immune tolerance and its loss in autoimmune disease as well as to development of antibodies with modified specificity.
This article has been cited by other articles:
|
|
 |
|
  B. Alabyev, R. Vuyyuru, and T. Manser Influence of Fas on the regulation of the response of an anti-nuclear antigen B cell clonotype to foreign antigen Int. Immunol., October 1, 2008; 20(10): 1279 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.M. Stinton, S.G. Barr, L.A. Tibbles, S. Yilmaz, A. Sar, H. Benedikttson, and M.J. Fritzler Autoantibodies in lupus nephritis patients requiring renal transplantation Lupus, June 1, 2007; 16(6): 394 - 400. [Abstract] [PDF]
|
|
|
|
 |
|
 E M Salonen, A Miettinen, T K Walle, S Koskenmies, J Kere, and H Julkunen Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases Ann Rheum Dis, October 1, 2004; 63(10): 1250 - 1254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Martin, H. Bradl, T. J. Collins, E. Roth, H.-M. Jack, and G. E. Wu Selection of Ig {micro} Heavy Chains by Complementarity-Determining Region 3 Length and Amino Acid Composition J. Immunol., November 1, 2003; 171(9): 4663 - 4671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A Mcneeley, G M Iverson, R A Furie, J M Cash, M E Cronin, R S Katz, M H Weisman, C Aranow, and M D Linnik Pre-treatment affinity for LJP 394 influences pharmacodynamic response in lupus patients Lupus, August 1, 2001; 10(8): 526 - 532. [Abstract] [PDF]
|
|
|
|
|
|
K. D. Klonowski and M. Monestier Heavy Chain Revision in MRL Mice: A Potential Mechanism for the Development of Autoreactive B Cell Precursors J. Immunol., October 15, 2000; 165(8): 4487 - 4493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Blank, A. Waisman, E. Mozes, T. Koike, and Y. Shoenfeld Characteristics and pathogenic role of anti-{beta}2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome Int. Immunol., December 1, 1999; 11(12): 1917 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. HUCK, E. DEVEAUD, A. NAMANE, and M. ZOUALI Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis FASEB J, August 1, 1999; 13(11): 1415 - 1422. [Abstract] [Full Text]
|
|
|
|
|
|
E. A. Whitcomb, B. B. Haines, A. P. Parmelee, A. M. Pearlman, and P. H. Brodeur Germline Structure and Differential Utilization of Igha and Ighb VH10 Genes J. Immunol., February 1, 1999; 162(3): 1541 - 1550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Klonowski, L. L. Primiano, and M. Monestier Atypical VH-D-JH Rearrangements in Newborn Autoimmune MRL Mice J. Immunol., February 1, 1999; 162(3): 1566 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zouali Signaling in human lupus T lymphocytes Lupus, October 1, 1998; 7(8): 499 - 502. [PDF]
|
|
|
|
|
|
Moinuddin, S Arjumand, and A Ali SLE autoantibodies binding to native calf thymus DNA brominated in high salt Lupus, October 1, 1998; 7(8): 524 - 529. [Abstract] [PDF]
|
|
|
|
 |
|
 B. H. Hahn Antibodies to DNA N. Engl. J. Med., May 7, 1998; 338(19): 1359 - 1368. [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Pisetsky Antibody Responses to DNA in Normal Immunity and Aberrant Immunity Clin. Vaccine Immunol., January 1, 1998; 5(1): 1 - 6. [Full Text]
|
|
|
|
 |
|
 A. A. Komissarov, M. T. Marchbank, M. J. Calcutt, T. P. Quinn, and S. L. Deutscher Site-specific Mutagenesis of a Recombinant Anti-single-stranded DNA Fab. ROLE OF HEAVY CHAIN COMPLEMENTARITY-DETERMINING REGION 3 RESIDUES IN ANTIGEN INTERACTION J. Biol. Chem., October 24, 1997; 272(43): 26864 - 26870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.A. Isenberg, C.T. Ravirajan, A. Rahman, and J. Kalsi The role of antibodies to DNA in systemic lupus erythematosus A review and introduction to an international workshop on DNA antibodies held in London, May 1996 Lupus, January 1, 1997; 6(3): 290 - 304. [PDF]
|
|
|
|
|
|
B.D. Stollar Why the Difference Between B-DNA and Z-DNA? Lupus, January 1, 1997; 6(3): 327 - 328. [PDF]
|
|
|
|
|
|
M. L. Cerutti, J. M. Centeno, F. A. Goldbaum, and G. de Prat-Gay Generation of Sequence-specific, High Affinity Anti-DNA Antibodies J. Biol. Chem., April 13, 2001; 276(16): 12769 - 12773. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
